2. EXECUTIVE SUMMARY Animascope is an R&D contract services company that specialises in multi-modality non-invasive biomedical imaging in vivo for discovery and preclinical exploratory research on animals in several therapeutic areas, onco, cardio, bones etc. In vivo visualisation of tissues, functions and dysfunctions, whole-body Cost-effective and time-effective approach Streamline discovery and preclinical studies Increase predictability of clinical outcomes Reduce experimental artifacts, Refine studies on animal models, Reduce the animal usage from 100% down to 20-30% To be earlier in the market Antonio 07Nov09
3. ANIMASCOPE INTEGRATED KNOWLEDGE TECHNOLOGY providers BIOMARKERS providers SOFTWARE providers FULL STUDY MANAGEMENT ANIMAL MODELS providers MANAGEMENT expertise Antonio 07Nov09 THERAPEUTIC expertise
11. Operations in Geneva, Lyon, St. Etienne (France)Antonio 07Nov09
12. NON-INVASIVE IN VIVO IMAGING Whole-body 3D detection of tissues and molecules reached unprecedented sensitivity and speed providing exclusive pathophysiology and anatomy readouts Bridges the gap between preclinical and clinical R&D Imaging means Metrics Quantitative, Precise, Predictive Reduces experimental Artifacts (in vivo) Longitudinal Studies -Reduce Animal Usage (minus 70-80%) Reduction and Refinement of animal works are Cost and Time-effective on R&D Antonio 07Nov09
14. IMAGING IN DRUG DISCOVERY AND DEVELOPMENT Studies on Drug Delivery and Liberation (drug to target) Efficacy, Safety, Pathology (desiderable and undesirable effects) Ligand-Target interaction (receptors, enzymes, transporters) including Dose Occupancy relationships Dynamic Biodistribution and Kinetics Imaging is suitable for ADME studies of NCE and Biologics In vivo studies of peptides, antibodies, cell therapies, nanoparticles, nutraceuticals, materials. Studies of pathophysiology, phenotyping, translational research and model validation studies Antonio 07Nov09
15. REDUCTION OF ANIMAL USAGETIME COURSE – HISTOPATH / AUTORAD Groups A B C D Antonio 07Nov09 E 1 2 3 4 5
22. X-RAY COMPUTED TOMOGRAPHY (CT) CT is well-suited for in vivo 3D analysis of Bone tissues at a high level of spatial resolution (10 µm). Using specific contrast media, can be used for anatomical and functional analysis of Soft tissues CT provides 3D anatomical images with spatial resolution 10-100 µm Antonio 07Nov09
23. MAGNETIC RESONANCE IMAGING (MRI) MRI provides anatomical, functional and metabolic images with or without the use of specific contrast media It is particularly suited for soft tissues such as brain and heart Routinely, spatial resolution varies around 100 µm in 3D Antonio 07Nov09
24. NUCLEAR IMAGINGPOSITRON EMISSION TOMOGRAPHY (PET)SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) An increasing number of radio-tracers are available (positron or gamma-emitters), permitting 3D whole-body evaluationof biochemical pathways, ligand-receptor binding, antibody-antigen distribution and energy metabolism (molecular imaging) Spatial resolution is close to 1 mm Antonio 07Nov09
25. OPTICAL IMAGING Using fluorescent and bioluminescent probes, in vivo whole-body imaging provides images related to specific biochemical pathways (molecular imaging) It is also well suited for biodistribution analysis, cell trafficking and functional genomics studies The number of markers available is rapidly increasing while 3D technologies for Quantitative Tomography are emerging as the golden standard in this field Antonio 07Nov09
26. ULTRASONOGRAPHY (US)Echography Many applications, including development and reproductive medicine studies Provides 2D anatomical information Combined with Doppler analysis allows evaluation of functional parameters, particularly in the cardiovascular and muscular fields The spatial resolution ranges from 30 to 100 µm Antonio 07Nov09
27. MULTI-MODALITY IMAGING X-ray CT and PET Dual Modality Function & Anatomy Optimise and Customise Each Protocol Multi-modality imaging allows to collect, combine and compare multiple readouts within the same anatomical structure and experimental frame Animascope utilizes a wide set of non-invasive technologies, all the main imaging techniques X-Ray CT, MRI, PET/SPECT, US, OPTIC Antonio 07Nov09 Courtesy of Siemens
43. Biomaterials, Bio-compatible materials, other MaterialsAntonio 07Nov09
44. TURNKEY SERVICES Our turnkey services are based on integrated services and multi-disciplinary skills. Customisable services and full studies are available depending on customer needs. Every project is tailored to optimize outcomes and readouts PROTOCOL DESIGN Definition of biological parameters to be measured Choice of imaging modalities, contrast agents, tracers, biomarkers Design of image processing workflow STUDY MANAGEMENT Model Pre-conditioning Image acquisition Recording and traceability IMAGE PROCESSING Image handling and pre-processing Data analysis REPORTING Technical reporting Biomedical reporting Antonio 07Nov09
50. ANIMAL MODELS Several models can be utilised, disease models and normal controls, including xenografts, mutants, pre-conditioned animals Several species can be used, such as mice, rats, guinea-pigs, microcebus, rabbits, and larger species Antonio 07Nov09
98. ANIMASCOPE CONTACT Animascope operates in Geneva, Lyon, St. Etienne (France) Contact: Antonio SERVADIO, Scientific Business Development www.animascope.eu a.servadio@animascope.eu Skype: animascope.eu Mobile: +39 338 7949623 www.animascope.eu Current Animascope office located near Grenoble New imaging facility near Geneva Antonio 07Nov09